SurgAR
Entry
2024
Hold
2yr
Status
Active
Who owns SurgAR?
SurgAR is a French HealthTech company, currently owned by Malakoff Humanis Innov' since 2024 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BYKey takeaways
- ·Co-held by Malakoff Humanis Innov', XAnge, Elaia Partners and Lazard Elaia Capital since 2024.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2024 · present
Malakoff Humanis Innov'Active
2024 · present(2yr) · MH Innov' · 2018 · VC
Lazard Elaia CapitalActive
2024 · present(2yr) · Elaia Digital Venture Fund V · 2024 · VC
Elaia PartnersActive
2024 · present(2yr) · DTS3 · 2024 · VC
XAngeActive
2024 · present(2yr) · XAnge 04 · 2021 · VC
More from DTS3
Other portfolio companies in the same fund.
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
Questions
Who owns SurgAR?
SurgAR is currently owned by Malakoff Humanis Innov', XAnge and 2 others, through DTS3, since 2024.
When did Malakoff Humanis Innov' and 3 others acquire SurgAR?
Malakoff Humanis Innov' and 3 others acquired SurgAR in 2024.
Who has owned SurgAR over time?
SurgAR has been through 4 private-equity ownership periods: Malakoff Humanis Innov' · via MH Innov' · since 2024; XAnge · via XAnge 04 · since 2024; Elaia Partners · via DTS3 · since 2024; Lazard Elaia Capital · via Elaia Digital Venture Fund V · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue